LSC Webinars
-
Harnessing mRNA Quality Insights: Essential Techniques For Rapid Drug Development
11/11/2024
Chief Scientific Officer and Founder Christian Cobaugh, Ph.D., examines the critical quality attributes of mRNA and LNPs that are pivotal to enhancing drug efficacy and safety.
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics
11/6/2024
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
How To Plan For Trouble-Free Filter Validation
10/28/2024
Watch to learn when filter validation should be performed, what is required from an end user and laboratory testing perspective, and how to achieve first-time success for various drug products.
-
Reducing Risks By Outsourcing OSD Manufacturing And Packaging
10/23/2024
Watch to discover the key benefits of outsourcing your OSD production and explore real-world examples and best practices to help you streamline your processes and enhance your operational agility.
-
Breaking Barriers: Combining Cell Line Development Innovation With Improved Process Development Workflows To Streamline Path To FIH
10/16/2024
Explore how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.
-
From Crisis To Confidence: Ensuring Smooth Regulatory Submissions
10/8/2024
Explore some of the major challenges that medical writing submission specialists face today and strategies that can consistently set the stage for success.
-
Strategic Antibody Outsourcing: Guidance On Selection, Services, And Facility Fit
9/24/2024
How do you choose the best CDMO for your program? In this presentation, experts share insights and best practices on selecting, qualifying, and managing CDMO partnerships.
-
Advances In Oral GLP-1 Analogs For Obesity
9/12/2024
Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.
-
Formulation Considerations For The Development Of High Concentration Biopharmaceuticals
9/11/2024
This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and present real-world case studies on how composition changes during the concentration process can be effectively characterized.
-
Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions
9/10/2024
Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.